Загрузка...
The patient journey toward a diagnosis of hereditary transthyretin (ATTRv) amyloidosis
BACKGROUND: Despite emerging treatments for hereditary transthyretin (ATTRv) amyloidosis, the disease is often misdiagnosed, with reported diagnostic delays of up to several years. Knowledge of the patient journey leading up to diagnosis may help to promote earlier intervention. The study’s objectiv...
Сохранить в:
| Опубликовано в: : | Orphanet J Rare Dis |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7798313/ https://ncbi.nlm.nih.gov/pubmed/33430941 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13023-020-01623-1 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|